These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 510382)

  • 21. Vasoactive intestinal peptide and PHI stimulate somatostatin release from rat cerebral cortical and diencephalic cells in dispersed cell culture.
    Tapia-Arancibia L; Reichlin S
    Brain Res; 1985 Jun; 336(1):67-72. PubMed ID: 2860951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous vasoactive intestinal peptide (VIP) regulates somatostatin secretion by cultured fetal rat cerebral cortical and hypothalamic cells.
    De los Frailes MT; Sanchez Franco F; Lorenzo MJ; Tolón RM; Lara JI; Cacicedo L
    Regul Pept; 1991 Jul; 34(3):261-74. PubMed ID: 1681571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of vasoactive intestinal peptide on the release of growth hormone in perifused pituitary and hypothalamus of the goat.
    Ogwuegbu SO; Hashizume T; Kanematsu S
    Domest Anim Endocrinol; 1991 Jan; 8(1):29-35. PubMed ID: 2013223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of VIP-stimulated intestinal secretion and cyclic AMP production by somatostatin in the rat.
    Carter RF; Bitar KN; Zfass AM; Makhlouf GM
    Gastroenterology; 1978 Apr; 74(4):726-30. PubMed ID: 204536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of kainic acid injections and other brain lesions on vasoactive intestinal peptide (VIP)-stimulated formation of cAMP in rat brain.
    Quik M; Emson PC; Fahrenkrug J; Iversen LL
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Apr; 306(3):281-6. PubMed ID: 38409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasoactive intestinal peptide stimulates renin secretion in vitro: evidence for a direct action of the peptide on the renal juxtaglomerular cells.
    Porter JP; Said SI; Ganong WF
    Neuroendocrinology; 1983 May; 36(5):404-8. PubMed ID: 6343909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation by secretin, vasoactive intestinal peptide, and somatostatin of cyclic AMP accumulation in cultured brain cells.
    van Calker D; Müller M; Hamprecht B
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6907-11. PubMed ID: 6109286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo studies of somatostatin-14 and somatostatin-28 biosynthesis in rat hypothalamus.
    Van Itallie CM; Fernstrom JD
    Endocrinology; 1983 Oct; 113(4):1210-7. PubMed ID: 6137359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Properties of vasoactive intestinal peptide-receptor interaction in rat liver membranes.
    Guerrero JM; Prieto JC; Ramírez-Cárdenas R; Calvo JR; Goberna R
    Rev Esp Fisiol; 1981 Mar; 37(1):1-8. PubMed ID: 6113623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of gastrointestinal and related hormones on glycogenolysis and gluconeogenesis in cultured liver cells.
    Matsumura M; Akiyoshi H; Fujii S
    J Biochem; 1977 Oct; 82(4):1073-6. PubMed ID: 924981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dexamethasone regulation of the prolactin release induced by vasoactive intestinal peptide (VIP)].
    Rotsztejn W; Benoist L; Besson J; Duval J
    C R Seances Acad Sci D; 1980 Mar; 290(12):791-3. PubMed ID: 6769606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasoactive intestinal peptide induces a transient release of growth hormone in the rat.
    Bluet-Pajot MT; Mounier F; Leonard JF; Kordon C; Durand D
    Peptides; 1987; 8(1):35-8. PubMed ID: 3575152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [PRF activity of VIP in vitro (author's transl)].
    Arancibia S; Enjalbert A; Ruberg M; Priam M; Bluet-Pajot MT; Kordon C
    J Physiol (Paris); 1981 Mar; 77(8):979-83. PubMed ID: 6122734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Release of somatostatin-like immunoreactivity from incubated rat hypothalamus and cerebral cortex. Effects of glucose and glucoregulatory hormones.
    Berelowitz M; Dudlak D; Frohman LA
    J Clin Invest; 1982 Jun; 69(6):1293-301. PubMed ID: 7045160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasoactive intestinal polypeptide (VIP)-sensitive adenylate cyclase in rat brain: regional distribution and localization on hypothalamic neurons.
    Kerwin RW; Pay S; Bhoola KD; Pycock CJ
    J Pharm Pharmacol; 1980 Aug; 32(8):561-6. PubMed ID: 6106694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of VIP, somatostatin and other peptides in the mouse vas deferens assay.
    Kastin AJ; Coy DH; Schally AV; Meyers CA
    Pharmacol Biochem Behav; 1978 Nov; 9(5):673-6. PubMed ID: 733857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatostatin inhibition of VIP-induced somatostatin release, cyclic AMP accumulation and 45Ca2+ uptake in diencephalic cells.
    Pares-Herbute N; Diaz J; Astier H; Tapia-Arancibia L
    Eur J Pharmacol; 1989 Feb; 161(2-3):241-4. PubMed ID: 2566490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Characterization of the stimulant effect of 2 neuropeptides (thyroliberin (TRH) and vasoactive intestinal peptide (VIP)) on the secretion of the growth hormone in the rat].
    Durand D; Bluet-Pajot MT; Mounier F; Leonard JF; Pressac M
    Reprod Nutr Dev (1980); 1987; 27(2B):481-9. PubMed ID: 3114836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasoactive intestinal peptide stimulates pancreatic somatostatin release.
    Ipp E; Dobbs RE; Unger RH
    FEBS Lett; 1978 Jun; 90(1):76-8. PubMed ID: 350630
    [No Abstract]   [Full Text] [Related]  

  • 40. Localization and developmental pattern of vasoactive intestinal polypeptide binding sites in the human hypothalamus.
    Sarrieau A; Najimi M; Chigr F; Kopp N; Jordan D; Rostene W
    Synapse; 1994 Jun; 17(2):129-40. PubMed ID: 8091302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.